[
    [
        {
            "time": "2020-10-14",
            "original_text": "医药生物行业2020三季度业绩前瞻：板块分化明显 医疗服务等板块有序复苏",
            "features": {
                "keywords": [
                    "医药生物",
                    "三季报",
                    "医疗服务",
                    "复苏"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2020三季度业绩前瞻：板块分化明显 医疗服务等板块有序复苏",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-10-13",
            "original_text": "A股融资融券日报：两融余额增加111.94亿元（10月13日）",
            "features": {
                "keywords": [
                    "两融余额",
                    "增加",
                    "A股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加111.94亿元（10月13日）",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-10-14",
            "original_text": "晨会聚焦201014重点关注丽人丽妆、交运行业、纺织服装、证券行业、有色行业、汽车行业",
            "features": {
                "keywords": [
                    "晨会聚焦",
                    "丽人丽妆",
                    "交运行业",
                    "纺织服装",
                    "证券行业",
                    "有色行业",
                    "汽车行业"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费",
                    "交通",
                    "纺织",
                    "金融",
                    "有色金属",
                    "汽车"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晨会聚焦201014重点关注丽人丽妆、交运行业、纺织服装、证券行业、有色行业、汽车行业",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-10-14",
            "original_text": "【中原医药】医药行业专题研究：换个角度看医药：从财务指标和估值来挖掘医药领域的投资机会",
            "features": {
                "keywords": [
                    "中原医药",
                    "专题研究",
                    "财务指标",
                    "估值",
                    "投资机会"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【中原医药】医药行业专题研究：换个角度看医药：从财务指标和估值来挖掘医药领域的投资机会",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-10-14",
            "original_text": "全球1000强药企最新排名出炉，恒瑞医药位列第21位",
            "features": {
                "keywords": [
                    "全球药企",
                    "恒瑞医药",
                    "排名",
                    "第21位"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "全球1000强药企最新排名出炉，恒瑞医药位列第21位",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-10-14",
            "original_text": "粤开策略流动性专题 | 9月量能持续低迷，北上布局顺周期板块",
            "features": {
                "keywords": [
                    "粤开策略",
                    "流动性",
                    "量能低迷",
                    "顺周期板块"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "经济周期"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "粤开策略流动性专题 | 9月量能持续低迷，北上布局顺周期板块",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-10-14",
            "original_text": "谊众药业闯关IPO：持续亏损需警惕 产品单一商业化前景堪忧 经营问题",
            "features": {
                "keywords": [
                    "谊众药业",
                    "IPO",
                    "亏损",
                    "产品单一",
                    "商业化前景"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "谊众药业闯关IPO：持续亏损需警惕 产品单一商业化前景堪忧 经营问题",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-10-14",
            "original_text": "【医药】三季报进入披露期，关注疫情动态和三季度业绩——医药行业周报——中性",
            "features": {
                "keywords": [
                    "医药",
                    "三季报",
                    "疫情动态",
                    "业绩"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药】三季报进入披露期，关注疫情动态和三季度业绩——医药行业周报——中性",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]